DARS1 and glioblastoma: Silencing DARS1-AS1 sensitized GBM cells to radiation, suggesting that targeting the DARS1-AS1/YBX1 axis could impair HR, making GBM cells susceptible to radiation and poly-ADP-ribose polymerase (PARP) inhibitors.